Literature DB >> 21601253

Effect of age on transitional cell carcinoma of the upper urinary tract: presentation, treatment, and outcomes.

Stanley A Yap1, Clayton W Schupp, Karim Chamie, Christopher P Evans, Theresa M Koppie.   

Abstract

OBJECTIVES: To determine the effect of age on the disease characteristics, treatment administered, and disease-specific survival (DSS) for patients with upper tract urothelial carcinoma. The effect of advancing age on the disease extent and survival has not been well delineated in patients with upper tract urothelial carcinoma.
METHODS: Using the Surveillance, Epidemiology, and End Results database from the National Cancer Institute, we identified patients diagnosed with UTUC from 1984 to 2004. The data were analyzed for age (40-49, 50-59, 60-69, 70-79, and ≥80 years), sex, race, disease extent, treatment type, and cause of death. Relationships among age, clinicopathologic features, and treatment were tabulated. The effect of age on overall and DSS were calculated using Cox proportional hazards ratio analyses.
RESULTS: The final cohort consisted of 12 639 patients. Advancing age was associated with greater T stage and grade at presentation. Of those 40-49 years old, 41% presented with invasive tumors (T2-T4) compared with 50% of octogenarians. Poor or undifferentiated tumors increased in frequency from 42% among those 40-49 years old to 59% among those≥80 years old. Extirpative surgery was less likely among those with Stage T1 or less disease (88.3% vs 92.8%). Octogenarians were less likely to have undergone extirpative surgery than those 40-49 years old (86% vs 95%). Despite adjustments for T stage, grade, and treatment, DSS (hazard ratio 2.64) worsened with increasing age.
CONCLUSIONS: With advancing age, we found a corresponding increase in stage and grade at presentation. After adjustment for stage, grade, and treatment type, older patients still had worse DSS.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21601253     DOI: 10.1016/j.urology.2011.03.032

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  14 in total

Review 1.  Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review.

Authors:  Aurélie Mbeutcha; Morgan Rouprêt; Ashish M Kamat; Pierre I Karakiewicz; Nathan Lawrentschuk; Giacomo Novara; Jay D Raman; Christian Seitz; Evanguelos Xylinas; Shahrokh F Shariat
Journal:  World J Urol       Date:  2016-04-21       Impact factor: 4.226

2.  Radical nephroureterectomy for UTUC conferred survival benefits irrespective of age and comorbidities.

Authors:  Jeremy Yuen-Chun Teoh; Chi-Fai Ng; Masatoshi Eto; Mallikarjuna Chiruvella; Umberto Capitanio; Tarik Esen; Guohua Zeng; Eric Lechevallier; Sero Andonian; Jean de la Rosette
Journal:  World J Urol       Date:  2022-09-20       Impact factor: 3.661

Review 3.  The prognostic significance of controlling nutritional status (CONUT) score for surgically treated renal cell cancer and upper urinary tract urothelial cancer: a systematic review and meta-analysis.

Authors:  Lei Peng; Chunyang Meng; Jinze Li; Chengyu You; Yuelin Du; Wei Xiong; Zhongyou Xia; Dehong Cao; Yunxiang Li
Journal:  Eur J Clin Nutr       Date:  2021-11-23       Impact factor: 4.884

4.  Assessment of Diagnostic Yield of Cystoscopy and Computed Tomographic Urography for Urinary Tract Cancers in Patients Evaluated for Microhematuria: A Systematic Review and Meta-analysis.

Authors:  Sharon Waisbrod; Anastasios Natsos; Marian Severin Wettstein; Karim Saba; Thomas Hermanns; Christian Daniel Fankhauser; Alexander Müller
Journal:  JAMA Netw Open       Date:  2021-05-03

Review 5.  Risk stratification for kidney sparing procedure in upper tract urothelial carcinoma.

Authors:  Zine-Eddine Khene; Romain Mathieu; Solène-Florence Kammerer-Jacquet; Thomas Seisen; Morgan Roupret; Shahrokh F Shariat; Benoit Peyronnet; Karim Bensalah
Journal:  Transl Androl Urol       Date:  2016-10

Review 6.  Predictive models and prognostic factors for upper tract urothelial carcinoma: a comprehensive review of the literature.

Authors:  Aurélie Mbeutcha; Romain Mathieu; Morgan Rouprêt; Kilian M Gust; Alberto Briganti; Pierre I Karakiewicz; Shahrokh F Shariat
Journal:  Transl Androl Urol       Date:  2016-10

7.  Preintervention risk stratification of renal pelvic cancer and ureteral cancer should differ.

Authors:  Tao Yang; Nan Zhang; Bo Yang; Dalin He; Junjie Fan; Jinhai Fan
Journal:  Investig Clin Urol       Date:  2020-05-27

8.  Risk stratification by means of biological age-related factors better predicts cancer-specific survival than chronological age in patients with upper tract urothelial carcinoma: a multi-institutional database study.

Authors:  Teruo Inamoto; Hideyasu Matsuyama; Naokazu Ibuki; Kazumasa Komura; Kiyohide Fujimoto; Hiroaki Shiina; Shigeru Sakano; Kazuhiro Nagao; Makito Miyake; Hiroaki Yasumoto; Haruhito Azuma
Journal:  Ther Adv Urol       Date:  2018-11-11

9.  Involvement of FGFR4 Gene Variants on the Clinicopathological Severity in Urothelial Cell Carcinoma.

Authors:  Ming-Dow Tsay; Ming-Ju Hsieh; Chia-Yi Lee; Shian-Shiang Wang; Chuan-Shu Chen; Sheng-Chun Hung; Chia-Yen Lin; Shun-Fa Yang
Journal:  Int J Environ Res Public Health       Date:  2019-12-23       Impact factor: 3.390

10.  Competing-risks nomogram for predicting cancer-specific death in upper tract urothelial carcinoma: a population-based analysis.

Authors:  Chengzhuo Li; Didi Han; Qiao Huang; Fengshuo Xu; Shuai Zheng; Xiang Li; Fanfan Zhao; Xiaojie Feng; Jun Lyu
Journal:  BMJ Open       Date:  2021-07-19       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.